
Jubilant Pharmova Ltd
NSE:JUBLPHARMA

Intrinsic Value
The intrinsic value of one
JUBLPHARMA
stock under the Base Case scenario is
864.85
INR.
Compared to the current market price of 895.9 INR,
Jubilant Pharmova Ltd
is
Overvalued by 3%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Jubilant Pharmova Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Jubilant Pharmova Ltd
Balance Sheet Decomposition
Jubilant Pharmova Ltd
Current Assets | 35B |
Cash & Short-Term Investments | 12.9B |
Receivables | 8.3B |
Other Current Assets | 13.8B |
Non-Current Assets | 84.2B |
Long-Term Investments | 631m |
PP&E | 42.7B |
Intangibles | 35.5B |
Other Non-Current Assets | 5.4B |
Free Cash Flow Analysis
Jubilant Pharmova Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Jubilant Pharmova Ltd
Revenue
|
70.6B
INR
|
Cost of Revenue
|
-22.2B
INR
|
Gross Profit
|
48.5B
INR
|
Operating Expenses
|
-41.2B
INR
|
Operating Income
|
7.3B
INR
|
Other Expenses
|
-981m
INR
|
Net Income
|
6.3B
INR
|
JUBLPHARMA Profitability Score
Profitability Due Diligence
Jubilant Pharmova Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Score
Jubilant Pharmova Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
JUBLPHARMA Solvency Score
Solvency Due Diligence
Jubilant Pharmova Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Score
Jubilant Pharmova Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
JUBLPHARMA Price Targets Summary
Jubilant Pharmova Ltd
According to Wall Street analysts, the average 1-year price target for
JUBLPHARMA
is 1 336.2 INR
with a low forecast of 1 247.35 INR and a high forecast of 1 454.25 INR.
Dividends
Current shareholder yield for JUBLPHARMA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
JUBLPHARMA
stock under the Base Case scenario is
864.85
INR.
Compared to the current market price of 895.9 INR,
Jubilant Pharmova Ltd
is
Overvalued by 3%.